• Seeking Alpha

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

Seeking Alpha / 4 hours ago 1 Views

$60.0M in 2Q25 Total Product Revenue

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Dorchester Minerals, L.P. Announces Second Quarter Results
Next post
LegalZoom Reports Strong Second Quarter 2025 Financial Results, Raises 2025 Revenue Growth Expectations

Comments

Just Posted

  • DarkIris Inc. Announces Pricing of Initial Public Offering

    3 hours from now

  • O2Gold Provides Update on Quebec Aur Transaction; Upsizes Private Placement Financing

    43 minutes from now

  • FLINT Announces Transformational Recapitalization

    27 minutes from now

  • BioVie Inc. Announces Pricing of $12 Million Public Offering

    26 minutes from now

  • Etoiles Capital Group Co., Ltd Announces Pricing of US$5.6 million Initial Public Offering

    16 minutes ago

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1384

Categories

  • Seeking Alpha 1384

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts